Kalbe Farma Tbk PT
XMUN:LCLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kalbe Farma Tbk PT
XMUN:LCLA
|
ID |
|
A
|
Abbott Laboratories
DUS:ABL
|
US |
|
Innocan Pharma Corp
F:IP4
|
IL |
Dividends
Dividend Yield
Kalbe Farma Tbk PT
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Kalbe Farma Tbk PT
LCLA have increased by 60%.
Payout Ratio
Kalbe Farma Tbk PT
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
LCLA is
.
Peers Comparison
Shareholder Yield
Price Appreciation
LCLA Price
Kalbe Farma Tbk PT
| Average Annual Return | -8.23% |
| Standard Deviation of Annual Returns | 27.5% |
| Max Drawdown | -77% |
| Market Capitalization | 35.5T EUR |
| Shares Outstanding | 46 255 641 410 |
| Percentage of Shares Shorted |
N/A
|